Back to all research

Selank: What the Research Says

July 7, 2026

Selank emerged from Russian peptide research and is studied primarily for its reported anxiolytic activity. This overview summarizes what the published research reports, strictly within a laboratory-research context.

What Is Selank?

Selank is a synthetic heptapeptide — an analog of the endogenous immunopeptide tuftsin (Thr-Lys-Pro-Arg), extended at the C-terminus with Pro-Gly-Pro to improve metabolic stability and duration of action.

Mechanisms Studied in Research

  • GABAergic modulation. Research describes Selank binding to and allosterically modulating GABA-A receptors, and altering expression of genes involved in GABAergic neurotransmission.
  • Anxiolytic activity. In animal models, Selank has been reported to have anxiolytic, antistress, and antidepressant-like activity; some studies note anxiolytic effects comparable to low doses of benzodiazepines in the models used, without the same side-effect profile.
  • Inflammation-related gene expression. Studies have examined Selank’s effects on inflammation-related genes, consistent with its tuftsin lineage.

The State of the Evidence

  • Largely preclinical / regional clinical. Much of the Selank literature comes from a specific research tradition; large multinational trials are limited.
  • Regulatory status. Selank is not an FDA-approved drug. Research-grade material is supplied for laboratory research use only.

Key Takeaways

  • Selank is a synthetic tuftsin-analog heptapeptide.
  • Research focuses on GABAergic modulation and anxiolytic activity in animal models.
  • It is not FDA-approved and is offered strictly for laboratory research.

References

  • “Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.” PMC5322660.
  • “Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.” Frontiers in Pharmacology, 2016.
  • “Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.” PMID 36322304.

Research Use, Legal Status & Handling

Material supplied for research is intended for in-vitro laboratory research use only. It is not a dietary supplement, drug, cosmetic, or food. Where an approved pharmaceutical version of a compound exists, research-grade material is not that approved product and is not intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Researchers are solely responsible for compliance with all applicable federal, state, and local laws and regulations in their jurisdiction. Research peptides are generally stored lyophilized, protected from light and heat, with reconstitution and handling performed per standard laboratory protocols.

Disclaimer: This article is provided for educational and informational purposes only and summarizes published laboratory and, where noted, clinical research. It is not medical advice or a recommendation for any form of use. Research-grade material is intended strictly for in-vitro research use only — not for human or veterinary consumption. Always consult a qualified professional regarding health-related questions.